Pasithea Therapeutics Corp. KTTA
0.50
(0.01)
(1.96%)
as of 25 Sep
- Market cap
- $17.2M
- P/E
- 0.0×
Follow KTTA
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(89.90%) | (58.36%) | (58.22%) | (65.49%) | |
| (83.64%) | (53.54%) | (55.58%) | (61.97%) | ||
ROIC |
(108.52%) | 0.00% | (319.73%) | (367.46%) | |
Return on Tangible Assets |
(325.00%) | (39.68%) | (38.51%) | (45.88%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(1.65) | (2.14) | (0.70) | (0.55) | |
Free Cash Flow |
(12.26) | (15.07) | (16.94) | (17.78) | |
Capital Expenditures |
— | 0.14 | — | — | |
| Other line items | |||||
Cash ROIC |
(74.60%) | (13.77%) | (16.09%) | (18.60%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.91 | 0.74 | 0.86 | 0.84 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.21 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.65) | (2.16) | (0.70) | (0.55) | |
Capex per Share |
0.00 | 0.02 | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates